The SURMOUNT-1 trial (Mounjaro) and the SCALE Obesity and Prediabetes trial (Saxenda) are the landmark studies for each medication
A doctor can help decide whether switching medications, adjusting dosage, or exploring other options will provide the safest and most effective results
Additionally, the FIGHT trial included 59% of patients with established type 2 diabetes, whereas the semaglutide HFpEF trials separately recruited patients with and without diabetes (STEP-HFpEF DM and STEP-HFpEF)
Vic ct gim calo mc d gip gim m nhng n c th nh hng trc tip n khi lng c bp bn vt v xy dng trc
Do we really think that these telehealth providers are not going to push them towards the Lilly version? Lurie said it will be interesting to see how the FDA reacts
Chair of RACGP Specific Interests Obesity Management and dietitian Dr Terri-Lynne South told newsGP it was interesting to see the product enter the market in a time of shortage, but the high price point of Wegovy would likely keep demand low
